Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of LXRɑ/β by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer

Published:2018-12 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Kim Soochi,Lee Maria,Dhanasekaran Danny N.,Song Yong Sang

Funder

Korea Health Industry Development Institute

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-5152-5.pdf

Reference49 articles.

1. Narod S. Can advanced-stage ovarian cancer be cured? Nat Rev Clin Oncol. 2016;13(4):255–61.

2. Kipps E, Tan DS, Kaye SB. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research. Nat Rev Cancer. 2013;13(4):273–82.

3. Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer. 2009;9(9):665–74.

4. Ahmed N, Stenvers KL. Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research. Front Oncol. 2013;3:256.

5. Kim S, Kim B, Song YS. Ascites modulates cancer cell behavior, contributing to tumor heterogeneity in ovarian cancer. Cancer Sci. 2016;107(9):1173–8.

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Why make it if you can take it: review on extracellular cholesterol uptake and its importance in breast and ovarian cancers;Journal of Experimental & Clinical Cancer Research;2024-09-06

2. MicroRNA-146b-5p/FDFT1 Mediates Cisplatin Sensitivity in Bladder Cancer by Redirecting Cholesterol Biosynthesis to the Non-Sterol Branch;The International Journal of Biochemistry & Cell Biology;2024-09

3. Vesicular drug delivery systems for oral absorption enhancement;CHINESE CHEM LETT;2024

4. Novel players in the development of chemoresistance in ovarian cancer: ovarian cancer stem cells, non-coding RNA and nuclear receptors;Cancer Drug Resistance;2024-02-28

5. Regulating Cholesterol in Tumorigenesis: A Novel Paradigm for Tumor Nanotherapeutics;International Journal of Nanomedicine;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3